Archer Investment Corporation’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22
Closed -$5.02K 1261
2026
Q1
$5.02K Hold
22
﹤0.01% 929
2025
Q4
$5.37K Sell
22
-878
-98% -$225K ﹤0.01% 860
2025
Q3
$246K Buy
900
+878
+3,991% +$240K 0.06% 239
2025
Q2
$5.73K Sell
22
-1,135
-98% -$271K ﹤0.01% 806
2025
Q1
$259K Hold
1,157
0.07% 223
2024
Q4
$265K Hold
1,157
0.07% 209
2024
Q3
$282K Buy
1,157
+1,135
+5,159% +$254K 0.08% 199
2024
Q2
$4.21K Buy
+22
New +$4.46K ﹤0.01% 806

Other funds holding RMD

Archer Investment Corporation's RMD Position: Q2 2026 in Review

Archer Investment Corporation sold out of ResMed (RMD) in Q2 2026, closing a stake of 22 shares — an estimated $5.02K sold.

Archer Investment Corporation first reported a position in RMD in Q2 2024 and held it in 8 quarters. The position peaked at $282K in Q3 2024. 605 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Archer Investment Corporation reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Archer Investment Corporation sold 22 ResMed shares in Q2 2026, an estimated $5.02K.
  • Archer Investment Corporation first reported a position in ResMed in Q2 2024 and held it in 8 quarters.
  • Archer Investment Corporation's ResMed position peaked at $282K in Q3 2024.
  • 605 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.